A polished telehealth brand may not be the medical practice or pharmacy. Before a prescription product leaves the building, a reader should be able to identify who prescribed it, who dispensed it, and whom to contact when something goes wrong.
Ask for the pharmacy name before shipment
With a retail brand prescription, the destination may be a familiar local or mail-order pharmacy. With a bundled compounded program, the pharmacy can depend on state, product, or capacity. Ask for the legal pharmacy name and location, not only “our partner pharmacy.”
The FDA recommends using a state-licensed pharmacy and offers consumer guidance on buying medicine safely online. The National Association of Boards of Pharmacy also provides tools for evaluating online pharmacy websites. A patient can contact the relevant state board if a license or complaint history needs clarification.
Read the label as an identity document
When a shipment arrives, compare the patient name, prescriber, pharmacy, drug or active ingredient, concentration, directions, lot information where shown, beyond-use or expiration date, and storage instructions with what the clinician explained. For a compounded vial, concentration deserves special attention because dose volume can differ.
Do not improvise when the label, syringe markings, or instructions are confusing. Contact the dispensing pharmacy and prescriber. The FDA has reported dosing errors involving compounded injectable semaglutide, including confusion across units of measure.
Inspect the package, not the marketing photo
Check whether a temperature-sensitive shipment arrived within the pharmacy’s stated range, whether seals are intact, and whether the contents match the packing list. Photograph damage and contact the pharmacy before using a product if storage conditions or identity are in doubt. Replacement policy should be part of the pre-purchase comparison.
Six pharmacy fields for every directory profile
- Pharmacy named publicly, named after intake, or not disclosed.
- Retail/mail-order brand route versus compounded fulfillment.
- State-specific assignment.
- Shipping and cold-chain terms.
- Patient support contact.
- Replacement, cancellation, and refill process.
GLP.directory does not rate the quality of a pharmacy without a documented methodology and current records. It does flag when the identity is absent, because opacity is itself useful information for a buyer.
Read the label as a responsibility map
The label should help identify the patient, prescriber, dispensing pharmacy, product, strength or concentration, directions, quantity, and relevant dates. Details differ by jurisdiction and product, but a consumer should not have to guess which licensed pharmacy dispensed the prescription or how to contact it. The consumer brand may answer order-status questions; the pharmacy owns dispensing and label questions.
Run a ten-point verification
- Does the site require a valid prescription and a meaningful clinical screen?
- Can you identify and contact the licensed prescriber or medical group?
- Can you identify the dispensing pharmacy before using the product?
- Does the relevant state board show an active license?
- Does the label match the expected patient, product, and instructions?
- Are the packaging and tamper protections intact?
- Did a refrigerated shipment arrive within the pharmacy’s stated conditions?
- Are lot, use-by, storage, and disposal instructions available where applicable?
- Can a pharmacist answer product-specific questions?
- Is there a clear route for replacement, complaint, or adverse-event reporting?
Know when not to troubleshoot alone
Do not infer a dose from a prior vial, an online chart, or the appearance of a syringe. If the concentration, unit markings, directions, storage, or product identity is unclear, pause and contact the prescriber and dispensing pharmacy. The FDA’s GLP-1 page reports dosing errors and quality concerns involving unapproved products, making source-specific instructions more important than generic advice.
For the broader buying decision, pair this checklist with the FDA-approved versus compounded explainer and the telehealth red-flag guide.
Sources: FDA consumer guidance on safe online pharmacies and unapproved GLP-1 drugs; NABP Safe Pharmacy resources. Checked September 10, 2026.
Source ledger
Primary and first-party sources
- U.S. Food and Drug Administrationfda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy ↗
- U.S. Food and Drug Administrationfda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss ↗
- safe.pharmacysafe.pharmacy/buy-safely ↗
These links support specific facts; inclusion is not an endorsement. Terms can change after the review date.
This report is general information, not medical advice. A licensed clinician who knows your history should guide treatment, prescribing, dosing, and switching decisions. Compounded drugs are not FDA approved.